A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
NCT07683065
·
clinicaltrials.gov ↗
RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Plaque Psoriasis
Metabolic Dysfunction-Associated Steatotic Liver Disease
Sponsor
Novartis Pharmaceuticals